Ultrasound in Medicine and Biology
Volume 34, Issue 3 , Pages 370-378 , March 2008

Myocardial Strain Analysis in a Doxorubicin-Induced Cardiomyopathy Model

  • Elena Piegari

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy
    • ,
  • Giovanni Di Salvo

      Affiliations

    • Department of Cardiology, Monaldi Hospital, Naples, Italy
    • Corresponding Author InformationAddress correspondence to: Giovanni Di Salvo, Department of Cardiology, Monaldi Hospital, Naples, Italy.
    • ,
  • Biagio Castaldi

      Affiliations

    • Department of Cardiology, Monaldi Hospital, Naples, Italy
    • ,
  • Maria Redenta Vitelli

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy
    • ,
  • Gabriella Rodolico

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy
    • ,
  • Paolo Golino

      Affiliations

    • Department of Cardiology, Monaldi Hospital, Naples, Italy
    • ,
  • Raffaele Calabrò

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy
    • ,
  • Francesco Rossi

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy
    • ,
  • Liberato Berrino

      Affiliations

    • Department of Experimental Medicine and Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Naples, Italy

Received 14 February 2007 ,Revised 30 July 2007 ,Accepted 2 August 2007.

References 

  1. Billingham ME. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In:  Silver MD editors. Cardiovascular Pathology. New York, NY: Churchill Livingstone; 1991;p. 1446–1486
  2. Cittadini A, Fazio S, D’Ascia C, Basso A, Bazzicalupo L, Picardi G, et al. Subclinical cardiotoxicity by doxorubicin: A pulsed Doppler echocardiographic study. Eur Heart J. 1991;12:1000–1005
  3. D’Hooge J, Heimdal A, Jamal F, Kukulski T, Bijnens B, Rademakers F, et al. Regional strain and SR measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr. 2000;1:154–170
  4. Di Salvo G, Drago M, Pacileo G, Rea A, Carrozza M, Santoro G, et al. Comparison of strain rate imaging for quantitative evaluation of regional left and right ventricular function after surgical versus percutaneous closure of atrial septal defect. Am J Cardiol. 2005;96:299–302
  5. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D’hooge J, et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol. 2007;99:974–977
  6. Goorin AM, Chauvenet AR, Terez-Atayade AR. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr. 1990;116:144–147
  7. Greenberg NL, Firstenberg MS, Castro PL, Main M, Travaglini A, Odabashian JA, et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation. 2002;105:99–105
  8. Hatle L, Sutherland GR. Regional myocardial function a new approach. Eur Heart J. 2000;21:1337–1357
  9. Hirano T, Asanuma T, Azakami R, Okuda K, Ishikura F, Beppu S. Noninvasive quantification of regional ventricular function in rats: assessment of serial change and spatial distribution using ultrasound strain analysis. J Am Soc Echocardiogr. 2005;18:907–912
  10. Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: A prospective blinded long-term observational study of outcome in 120 patients. Ann Oncol. 2002;13:699–709
  11. Koiwa Y, Kanai H, Hasegawa H, Saitoh Y, Shirato K. Left ventricular transmural systolic function by high-sensitivity velocity measurement “phased-tracking method” across the septum in doxorubicin cardiomyopathy. Ultrasound Med Biol. 2002;28:1395–1403
  12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  13. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17:1021–1029
  14. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808–815
  15. Matoba S, Hwang PM, Nguyen T, Shizukuda Y. Evaluation of pulsed Doppler tissue velocity imaging for assessing systolic function of murine global heart failure. J Am Soc Echocardiogr. 2005;18:148–154
  16. Matre K, Fannelop T, Dahle GO, Heimdal A, Grong K. Radial strain gradient across the normal myocardial wall in open-chest pigs measured with Doppler strain rate imaging. J Am Soc Echocardiogr. 2005;18:1066–1073
  17. Meinardi MT, Van Veldhuisen DJ, Gietema JA, Dolsma WV, Boomsma F, van den Berg MP, et al. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol. 2001;19:2746–2753
  18. Marchandise B, Schroeder E, Bosly A, Doyen C, Weynants P, Kremer R, et al. Early detection of doxorubicin cardiotoxicity: Interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J. 1989;118:92–98
  19. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185–229
  20. Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol. 2003;92:1434–1438
  21. Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES, et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J. 2006;27:1868–1875
  22. Rodrigues AC, Hataishi R, Ichinose F, Bloch KD, Derumeaux G, Picard MH, et al. Relationship of systolic dysfunction to area at risk and infarction size after ischemia-reperfusion in mice. J Am Soc Echocardiogr. 2004;17:948–953
  23. Rossi F, Filippelli W, Russo S, Filippelli A, Berrino L. Cardiotoxicity of doxorubicin: Effects of drugs inhibiting the release of vasoactive substances. Pharmacol Toxicol. 1994;75:99–107
  24. Saha DC, Saha AC, Malik G, Astiz ME, Rackow EC. Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats. J Am Assoc Lab Anim Sci. 2007;46:74–80
  25. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339:900–905
  26. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672–1677
  27. Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J, et al. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992;20:62–69
  28. Sung RY, Huang GY, Shing MK, Oppenheimer SJ, Li CK, Li CK, et al. Echocardiographic evaluation of cardiac function in pediatric oncology patients treated with or without anthracyclines. Int J Cardiol. 1997;60:239–248
  29. Sutherland GR, Di Salvo G, Claus P, D’Hooge J, Bijnens B. Strain and strain rate imaging: A new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr. 2004;17:788–802
  30. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by Doppler echocardiography validation of a new method to quantify regional myocardial function. Circulation. 2000;102:1158–1164
  31. Weytjens C, Cosyns B, D’hooge J, Gallez C, Droogmans S, Lahoute T, et al. Doppler myocardial imaging in adult male rats: Reference values and reproducibility of velocity and deformation parameters. Eur J Echocardiogr. 2006;7:411–417
  32. Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110:3081–3087
  33. Yinbo L, Garson C, Epstein FH, French BA, Hossack JA. High resolution 2D quantification of myocardial motion abnormalities in mice using high resolution ultrasound with MRI validation. Biomedical Imaging: Macro to Nano, 2006. In: 2006;p. 630–6333rd IEEE International Symposium, April 6–9

PII: S0301-5629(07)00395-X

doi: 10.1016/j.ultrasmedbio.2007.08.002

Ultrasound in Medicine and Biology
Volume 34, Issue 3 , Pages 370-378 , March 2008

Article Tools

* Image Usage & Resolution